International Community Should Pool Resources To Address Threats Of Antibiotic Resistance, Infectious Diseases

Project Syndicate: The Global Security Threat of Antimicrobial Resistance
Tadataka Yamada, venture partner at Frazier Healthcare Partners

“…The global threat of emerging or resistant infections must be viewed first and foremost in [the context of investing in national defense and security], with all countries committed to providing financing, intellectual capital, and available resources to support the discovery, development, manufacture, stockpiling, and equitable distribution of new antimicrobial agents and vaccines. … Country investments should be pooled to create a substantial pipeline of products to combat infectious threats. … An alternative would be to create a full-fledged, global, not-for-profit pharmaceutical company with a research budget equal to that of the world’s top five for-profit companies, and with the singular objective of creating a pipeline of products to address the challenge of infectious threats. … It goes without saying that this would be a complicated undertaking, with many details to be worked out. But somehow we must suspend disbelief and take action now, lest we be caught off-guard against an imminent global threat. This is a battle we cannot afford to lose” (7/27).

The KFF Daily Global Health Policy Report summarized news and information on global health policy from hundreds of sources, from May 2009 through December 2020. All summaries are archived and available via search.

The Henry J. Kaiser Family Foundation Headquarters: 185 Berry St., Suite 2000, San Francisco, CA 94107 | Phone 650-854-9400
Washington Offices and Barbara Jordan Conference Center: 1330 G Street, NW, Washington, DC 20005 | Phone 202-347-5270

www.kff.org | Email Alerts: kff.org/email | facebook.com/KaiserFamilyFoundation | twitter.com/kff

Filling the need for trusted information on national health issues, the Kaiser Family Foundation is a nonprofit organization based in San Francisco, California.